Process View
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydroxyisoflavone stimulus.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cellular response to hydroxyisoflavone"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| GABRA3 | gamma-aminobutyric acid (GABA) A receptor, alpha 3 | 0.973 | ||
| UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 | 0.923 | Human | |
| UGT2B15 | UDP glucuronosyltransferase 2 family, polypeptide B15 | 0.918 | Human | |
| UGT1A3 | UDP glucuronosyltransferase 1 family, polypeptide A3 | 0.321 | ||
| UGT1A1 | UDP glucuronosyltransferase 1 family, polypeptide A1 | 0.319 | ||
| UGT2B28 | UDP glucuronosyltransferase 2 family, polypeptide B28 | 0.116 | Human | |
| NR1H4 | nuclear receptor subfamily 1, group H, member 4 | 0.095 | ||
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.093 | ||
| UGT2B4 | UDP glucuronosyltransferase 2 family, polypeptide B4 | 0.086 | Human | |
| SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.084 | ||
| LRRC31 | leucine rich repeat containing 31 | 0.063 | ||
| SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | 0.062 | ||
| CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.060 | ||
| CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.054 | ||
| PRLR | prolactin receptor | 0.053 | ||
| SI | sucrase-isomaltase (alpha-glucosidase) | 0.053 | ||
| SLCO1B3 | solute carrier organic anion transporter family, member 1B3 | 0.050 | ||
| UGT1A7 | UDP glucuronosyltransferase 1 family, polypeptide A7 | 0.049 | ||
| GYS2 | glycogen synthase 2 (liver) | 0.046 | ||
| HRG | histidine-rich glycoprotein | 0.040 | ||
| CYP2C18 | cytochrome P450, family 2, subfamily C, polypeptide 18 | 0.040 | ||
| CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 0.039 | ||
| CDH17 | cadherin 17, LI cadherin (liver-intestine) | 0.039 | ||
| F13B | coagulation factor XIII, B polypeptide | 0.038 | ||
| OTC | ornithine carbamoyltransferase | 0.036 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.035 | ||
| GC | group-specific component (vitamin D binding protein) | 0.034 | ||
| SULT1E1 | sulfotransferase family 1E, estrogen-preferring, member 1 | 0.034 | ||
| SLC26A3 | solute carrier family 26, member 3 | 0.031 | ||
| MBL2 | mannose-binding lectin (protein C) 2, soluble | 0.031 | ||
| CYP7A1 | cytochrome P450, family 7, subfamily A, polypeptide 1 | 0.030 | ||
| UGT2A3 | UDP glucuronosyltransferase 2 family, polypeptide A3 | 0.027 | Human | |
| HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | 0.026 | ||
| PAH | phenylalanine hydroxylase | 0.026 | ||
| UGT2B10 | UDP glucuronosyltransferase 2 family, polypeptide B10 | 0.025 | Human | |
| KNG1 | kininogen 1 | 0.025 | ||
| LECT2 | leukocyte cell-derived chemotaxin 2 | 0.024 | ||
| UGT1A9 | UDP glucuronosyltransferase 1 family, polypeptide A9 | 0.024 | ||
| NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | 0.023 | ||
| ANGPTL3 | angiopoietin-like 3 | 0.023 | ||
| HNF4G | hepatocyte nuclear factor 4, gamma | 0.023 | ||
| HAO1 | hydroxyacid oxidase (glycolate oxidase) 1 | 0.023 | ||
| PDZK1 | PDZ domain containing 1 | 0.022 | ||
| ADH6 | alcohol dehydrogenase 6 (class V) | 0.022 | ||
| CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 0.021 | ||
| CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 0.021 | ||
| G6PC | glucose-6-phosphatase, catalytic subunit | 0.021 | ||
| HGD | homogentisate 1,2-dioxygenase | 0.021 | ||
| CYP8B1 | cytochrome P450, family 8, subfamily B, polypeptide 1 | 0.020 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.020 | ||
| CPB2 | carboxypeptidase B2 (plasma) | 0.020 | ||
| ANXA10 | annexin A10 | 0.019 | ||
| AADAC | arylacetamide deacetylase (esterase) | 0.019 | ||
| FRK | fyn-related kinase | 0.019 | ||
| F9 | coagulation factor IX | 0.019 | ||
| ZNF157 | zinc finger protein 157 | 0.019 | ||
| AFM | afamin | 0.018 | ||
| ACE2 | angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 | 0.018 | ||
| TAT | tyrosine aminotransferase | 0.017 | ||
| FGG | fibrinogen gamma chain | 0.017 | ||
| DDC | dopa decarboxylase (aromatic L-amino acid decarboxylase) | 0.017 | ||
| SULT1C2 | sulfotransferase family, cytosolic, 1C, member 2 | 0.017 | ||
| ADH4 | alcohol dehydrogenase 4 (class II), pi polypeptide | 0.016 | ||
| TPH1 | tryptophan hydroxylase 1 | 0.016 | ||
| TFF3 | trefoil factor 3 (intestinal) | 0.016 | ||
| TSPAN8 | tetraspanin 8 | 0.016 | ||
| MEP1A | meprin A, alpha (PABA peptide hydrolase) | 0.015 | ||
| CLDN8 | claudin 8 | 0.015 | ||
| AKR1D1 | aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase) | 0.015 | ||
| AKR1C4 | aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) | 0.015 | ||
| ENTPD5 | ectonucleoside triphosphate diphosphohydrolase 5 | 0.015 | ||
| OR5P2 | olfactory receptor, family 5, subfamily P, member 2 | 0.015 | ||
| PKHD1 | polycystic kidney and hepatic disease 1 (autosomal recessive) | 0.014 | ||
| MIA2 | melanoma inhibitory activity 2 | 0.014 | ||
| SULT1B1 | sulfotransferase family, cytosolic, 1B, member 1 | 0.014 | ||
| MTTP | microsomal triglyceride transfer protein | 0.014 | ||
| NR5A2 | nuclear receptor subfamily 5, group A, member 2 | 0.014 | ||
| HTN3 | histatin 3 | 0.014 | ||
| CFHR4 | complement factor H-related 4 | 0.014 | ||
| SLC30A10 | solute carrier family 30, member 10 | 0.013 | ||
| ACSM2A | acyl-CoA synthetase medium-chain family member 2A | 0.013 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.013 | ||
| TTPA | tocopherol (alpha) transfer protein | 0.013 | ||
| LGSN | lengsin, lens protein with glutamine synthetase domain | 0.013 | ||
| FMO5 | flavin containing monooxygenase 5 | 0.013 | ||
| CCDC68 | coiled-coil domain containing 68 | 0.013 | ||
| GSTA3 | glutathione S-transferase alpha 3 | 0.013 | ||
| NPY1R | neuropeptide Y receptor Y1 | 0.012 | ||
| SLCO1B1 | solute carrier organic anion transporter family, member 1B1 | 0.012 | ||
| SPO11 | SPO11 meiotic protein covalently bound to DSB homolog (S. cerevisiae) | 0.012 | ||
| SOSTDC1 | sclerostin domain containing 1 | 0.012 | ||
| MSTN | myostatin | 0.012 | ||
| CPS1 | carbamoyl-phosphate synthase 1, mitochondrial | 0.012 | ||
| SLC25A21 | solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21 | 0.012 | ||
| KERA | keratocan | 0.012 | ||
| MAP2K6 | mitogen-activated protein kinase kinase 6 | 0.012 | ||
| CRISP3 | cysteine-rich secretory protein 3 | 0.012 | ||
| ACPP | acid phosphatase, prostate | 0.011 | ||
| AKAP7 | A kinase (PRKA) anchor protein 7 | 0.011 | ||
| HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 | 0.011 | ||
| EGF | epidermal growth factor | 0.011 | ||
| HTN1 | histatin 1 | 0.011 | ||
| ALDOB | aldolase B, fructose-bisphosphate | 0.011 | ||
| GLYAT | glycine-N-acyltransferase | 0.011 | ||
| LRRC19 | leucine rich repeat containing 19 | 0.011 | ||
| CYP4F3 | cytochrome P450, family 4, subfamily F, polypeptide 3 | 0.011 | ||
| CLRN3 | clarin 3 | 0.011 | ||
| XK | X-linked Kx blood group (McLeod syndrome) | 0.010 | ||
| APOM | apolipoprotein M | 0.010 | ||
| HSD17B6 | hydroxysteroid (17-beta) dehydrogenase 6 homolog (mouse) | 0.010 | ||
| AGXT2 | alanine--glyoxylate aminotransferase 2 | 0.010 | ||
| FMO3 | flavin containing monooxygenase 3 | 0.010 | ||
| HEPACAM2 | HEPACAM family member 2 | 0.010 | ||
| AFP | alpha-fetoprotein | 0.010 | ||
| ALDH8A1 | aldehyde dehydrogenase 8 family, member A1 | 0.010 |